In 2010, NIAID established a coordinating committee composed of professional organizations, federal agencies, and patient advocacy groups to oversee development of concise clinical guidelines for health care professionals on the diagnosis and management of food allergy and the treatment of acute food allergy reactions.
Findings from a landmark NIAID-funded clinical trial reported in 2015 called LEAP showed that introducing peanut-containing foods to infants at high risk for developing peanut allergy was safe and led to an 81 percent relative reduction in the subsequent development of peanut allergy. Based on the strength of these results, NIAID reestablished the coordinating committee and convened an expert panel to update the 2010 Guidelines to specifically address the prevention of peanut allergy. Read the NIAID press release on LEAP.
Draft addendum guidelines were available on the NIAID website for public comment from March 4, 2016, to April 18, 2016. The expert panel members and NIAID will review and take into account the comments received to revise the guidelines, which will then be sent to the coordinating committee for final approval.
View the 2015 Expert Panel and Coordinating Committee rosters.
Read or download a copy of the independent, systematic literature review which was used in conjunction with consensus expert opinion to develop the guidelines.
See a list of resources and dates of public presentations about the guidelines.
Learn more about the process used to produce the guidelines:
Last Updated April 18, 2016